Transaction · 0001638643-26-000010

O'Day Daniel Patrick

O'Day Daniel Patrick, CHAIR, CEO, reported an open-market or private sale at GILEAD SCIENCES, INC. involving 115640.000000 shares for an estimated $17346000.00. Reported holdings after the transaction were 613912.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCHAIR, CEO
GILDGILEAD SCIENCES, INC.
Filing timeFeb 06
Trade dateFeb 05, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$152.50
Pre-filing
1mo ago -20.4%1w ago -8.5%1d ago -4.1%
Returns since
7d +1.6%30d -5.6%90d -12.1%180d -13.6%1y -4.5%

GILD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
GILD since 2026-02-06Filed 209 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001638643-26-000010
Common Stock
Transaction date
Feb 05, 2026
Filed Feb 06, 2026, 09:22 PM · 1d delay
Shares
115k sh
$15.0k per share
Estimated value
-$1.73B
Computed from shares × price
Holdings after
613k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Sale 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chairman & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.

  2. F2

    The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully veste…

Original filing · 0001638643-26-000010
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

GILD